SUHEUNG Co., Ltd.

上海 2024年3月8日 /美通社/ -- 由中国医药保健品进出口商会与上海博华国际展览有限公司联合主办的"第十四届中国国际健康产品展览会、2024亚洲天然及营养保健品展（简称HNC健康营养展）"将于2024年6月19-21日在国家会展中心（上海）隆重举办，与食品加工包装系列展同期举办大健康产业链一站式商贸盛会，总展示面积达200,000平方米，现场将有超过2,000家参展商、近百场专业论坛峰会，观众预计将达到100,000人次。届时，众多行业内的线上和线下渠道商将齐聚现场，与来自海内外知名大健康品牌以及制造业巨头汇聚一堂，共同抢占国内外商贸机遇，深入了解权威和前沿的行业资讯。 破解行业内卷，打造商贸交流核心阵地 随着人们的健康意识不断提高，从健康产品到健康服务再到健康教育等，健康管理的消费领域在不断拓展。新需求使消费市场不断外延、细分，也使得健康消费保持持续火热的态势。消费者的服务需求也从单一产品销售服务提升到全生命周期、全方面健康管理，导致大健康消费领域竞争加剧。当"内卷"一词在大健康行业愈演愈烈，大健康企业到底该如何应对？ HNC健康营养展作为嗅觉敏锐、前瞻创新的行业前行者，为供需双方搭建了一个 独有 的商贸平台来凸显企业独特的竞争优势，助力健康营养企业与时俱进地感知新需求、挖掘新产品、探索新技术、捕捉新机遇、开辟新跑道，破解行业内卷！2024年HNC健康营养展将打造一个集海外膳食补充剂、食疗滋补、母婴营养、抗衰美容、情绪管理、宠物保健、保健品包装、地方特色营养品于一体的多元化营养保健品贸易展会。通过国际展区来加强国内外企业交流，鼓励国内生产企业"走出去"，带动产业链和供应链的供应，扩大国际产能合作；通过打造宠物保健和保健品包装品专区类来引领跨界融合、为创新加码；同时，展会期间还有各类政策法规、技术研发、营销应用、线下渠道对接等论坛活动，帮助企业细分产品、细分技术、细分市场，打造差异化产品，从红海驶入蓝海，也是一个减少内卷的选择。 重塑国际格局，搭建中外经贸往来桥梁 随着国家出入境管理政策措施的逐步优化，出入境流量日渐回升，海内外交流将进一步恢复活力。2024年国际品牌区吸引了众多国际品牌商及生产商纷纷入驻，现场将迎来澳大利亚、新西兰、日本、韩国、马来西亚、新加坡、德国等多个国家和地区的海外品牌集体亮相，包括澳佳宝（BLACKMORES）、澳乐维他（Enervite）、蓝桉制药（Bluegum Pharmaceuticals）、德国星空制药（Starsky Pharma）、森永制果（MORINAGA）、IFF、Lavida、NOVAREX、AB-BIOTICS、ILDONG BIOSCIENCE、Robinson、Suheung、Invapharm、罗赛洛、ADM等。HNC海外展团帮助企业拓展国内渠道，获得更大的市场份额，在提高品牌知名度的同时，融入中国的商业生态系统。同时，展会现场还将举办"美国药典膳食补充剂标准与质量体系认证"研讨会，来自USP中国/美国、行业协会、产业界的资深专家就膳食补充剂的质量标准、质量体系管理、认证、出口注册申报等方面，与参会代表进行现场交流和讨论，为提升中国膳食补充剂企业的产品质量提供指导和帮助，提高其在国际与国内市场的地位和竞争力 。 HNC健康营养展-现场回顾1 布局全新赛道，拓宽营销渠道商贸链路 除了重塑国际格局，HNC健康营养展也主张唤醒年轻人的"滋补养生血脉"。据《Z世代营养消费趋势报告》显示，年轻人正成为养生消费的主力军，其中18至35岁的年轻消费人群占比高达83.7%，"药食同源+滋补类"成为新生代消费首选。为此，专属于HNC健康营养展的明星专区"中华精品区"也将在2024年华丽升级为"药食滋补区"。众多企业在原有传统养生滋补品类上推陈出新，同仁堂、滋补堂、芝神堂、北达苁蓉、江苏泓寿、康能生物、黄山云乐、五养堂、苁蓉堂、仙芝楼、仙芝灵、徽百堂等知名品牌及生产企业将携新品亮相展会现场，如即食花胶、即食燕窝、熬制凉茶、阿胶糕、中药饮片、灵芝、人参、燕窝、铁皮石斛、冬虫夏草加工制品、保健茶、保健酒等等。HNC将帮助传统滋补企业打通营销链路，实现品牌核心优势的有效传递，为企业布局茶饮、食疗新赛道！与此同时，展会现场还将配套"西藏拉萨经开区净土健康产业招商引资推介会"和"2024中国吉林人参健康（上海）论坛"，西藏自治区和吉林省将携特优新企业借力HNC健康营养展，加强与大健康上下游企业的合作交流，助力地域特色产品开拓渠道，走向更广阔的市场。 除此之外，HNC健康营养展现场还将汇聚500多家国内知名品牌，包括：仙乐健康、森澜生物、百岳特、湖北跃海、宁波吉典、优能生物、威海百合、艾兰得、康恩萃、时代生物、华润圣海、科丝美诗纽芝丽、全惠康、大闽食品、根莱食品、柏维力、葡萄王、逢时健康、健特药业、亿超生物、菌钥、新西兰联合制药、天美健、新维士、诚一大健康、纽斯葆广赛、永安康健、广东微量元素、惠松制药等等。 紧跟产业动向，输出政策法规最新趋势 今年展会期间，主办方将为海内外参展企业和所有观众带来70多场高品质的行业活动，形式内容丰富，从政策法规解读会、细分行业专业论坛、线上线下渠道对接会、企业经验交流会、新品发布会等活动应有尽有。通过全方位、高水准、多角度的深层挖掘，使得营养保健品行业专业人士在参与活动挖掘商机之余，也能拓展社交人脉。 HNC健康营养展-现场回顾2 其中，展会连续第十一年精心打造的主场论坛：第十一届中国营养保健产业高峰论坛，将邀请国家市场监督管理总局、商务部、海关等政府机构及专家共聚一堂，从监管政策、跨境电商、市场通路、发展趋势等产品进入中国亟需解决的问题为企业答疑解惑。除此以外，创新汇·中国营养与保健食品行业创新论坛、第六届营养与特殊食品论坛、全国低GI·全谷物·植物基食品健康论坛、第十二届营养健康产业发展论坛、第八届特殊医学用途配方食品论坛、2024快消品大健康产业创新论坛、第七届大健康品牌营销实战应用论坛、连锁商超配对会、连锁药店配对会等多场专业论坛活动都将精彩上演，期待您的参与 。 2024年6月19-21日，我们诚挚地期盼与您相聚于上海虹桥国家会展中心，共同见证这一次的大健康产业盛会。作为深耕大健康行业多年的标杆品牌盛会，HNC健康营养展将秉承一贯的品质，为参展商和观众呈现多元化业态价值，推进全行业的高质量发展，促进大健康产业持续升级。让我们携手共筑健康营养新未来 。 关注 微信公众号"HNC健康营养展"，或访问官方网站 www.hncexpo.com ，了解更多专业资讯 。

Individuals who use Ginger’s on-demand behavioral health platform can now receive and manage their mental health medications from home, thanks to a new partnership with digital pharmacy Capsule. After users complete a consultation with one of Ginger’s board-certified psychiatrists, they will be given the option to fill their prescriptions through Capsule, including free home delivery in select locations. Same-day medication delivery is currently available in metro areas of New York City, Chicago, Minneapolis, Boston and Austin, with additional regions expected to be added in the coming weeks and months, Ginger said in its announcement. Ginger’s prescribing psychiatrists will be armed with medication fill rates and adverse events data from Capsule’s platform to better inform their oversight of patient medication regimens. Additionally, this partnership can save Ginger’s employer partners money by ensuring their workers are getting the mental health support they need to be productive, as well as by mitigating inappropriate fillings that could lead to adverse outcomes, according to Dr. Jon Kole, the director of psychiatry at Ginger. WHY THIS MATTERS Through this partnership, Ginger hopes to close a number of care gaps in psychiatry that exist today. The first being to support patients who need mental health interventions. More than 13% of U.S. adults used antidepressants between 2015 and 2018 according to a National Center for Health Statistics survey. “We’re talking about a cohort of people that are coming to care, which can take a big leap to start mental health services and already are stressed,” Kole told MobiHealthNews. “So if we can do anything to reduce the stress of starting a treatment or make things a little bit easier for that cohort, we should.” It comes at a time when the need for mental health services is rising. By last June, 40% of U.S. adults reported struggling with mental health or substance abuse, according to the Centers for Disease Control and Prevention. Further, Ginger says it has seen a 335% increase in demand for its services from before the pandemic to January 2021. The partnership also hopes to address an ongoing lack of professional supervision over their patients’ medication plans. Less than one-third of Americans who take a single antidepressant medication have seen a mental health professional in the last year, according to a separate NCHS survey. Among traditional deliveries of psychiatric care, there’s a gap where medication is prescribed to the patient, sent to the pharmacy and then to the patient, who is left to manage their own medication from there, Kole said. “With this feedback, we’ll get reports on what’s getting filled and what’s not getting filled,” he said. “We’re going to avoid inappropriate medication refills, [and] gaps in care, and that’s going to help continue the pattern of Ginger’s outcomes being really good.” THE LARGER TREND There’s no shortage of digital mental health tools on the market today. Other big names in the space that have recently made headlines include Lyra Health, Talkspace and Modern Health. Last year, Ginger acquired fellow digital mental-wellness company LiveBetter's technology assets. The company also completed a $50 million Series D funding round, bringing its total funding to more than $120 million. Back in 2019, Capsule raised $200 million to help it expand its services beyond New York City.

Capsule Technologies, established in 1997, serves more than 2,800 hospitals and healthcare organisations in 40 countries Philips has agreed to acquire Capsule Technologies. (Credit: Koninklijke Philips N.V.) Health technology company Royal Philips has agreed to acquire Francisco Partners portfolio company Capsule Technologies for a cash consideration of $635m. Based in Andover of Massachusetts, Capsule Technologies offers medical device integration and data technologies for hospitals and healthcare organisations. Established in 1997, the company serves more than 2,800 hospitals and healthcare organisations in 40 countries across the world. Capsule provides Medical Device Information Platform, which consists of device integration, vital signs monitoring, and clinical surveillance solutions that help connect all existing medical devices and EMRs in hospitals via a vendor-neutral system. The platform acquires streaming clinical data from connected systems and converts it into actionable information for clinical documentation, alarm management, patient surveillance, decision support, predictive analytics and clinical research. Capsule acquisition to boost Philips’ integrated solutions The acquisition of Capsule will allow Philips to boost its delivery of care along the health continuum with integrated solutions. Philips’ current portfolio already consists of real-time patient monitoring, therapeutic devices, telehealth, informatics and interoperability solutions. Connected through Philips’ secure vendor-neutral cloud-based HealthSuite digital platform, the combination of Philips’ portfolio and Capsule’s Medical Device Information Platform is expected to enable Philips to enhance patient care management solutions for all care settings in the hospital and remote patient care. Royal Philips connected care chief business leader Roy Jakobs said: “The acquisition of Capsule will further expand our patient care management offering. “We look forward to integrating our strengths, adding a vendor-neutral medical device integration platform that further unlocks the power of medical device data to enhance patient monitoring and management, improve collaboration and streamline workflows in the ICU, as well as other care settings in the hospital and beyond its walls.” Subject to certain closing conditions including regulatory clearances in relevant jurisdictions outside of the US, the deal is expected to be completed in the first quarter of 2021. Following the completion of the transaction, Capsule and its approximately 300 employees will become part of Philips’ connected care segment. In December 2020, Philips reached a definitive merger agreement with remote medical monitoring technology firm BioTelemetry, worth $2.8bn.